nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomustine—Alkylating Activity—Temozolomide—skin cancer	0.46	0.556	CiPCiCtD
Lomustine—Alkylating Activity—Dacarbazine—skin cancer	0.368	0.444	CiPCiCtD
Lomustine—CYP3A4—Imiquimod—skin cancer	0.0299	0.233	CbGbCtD
Lomustine—CYP3A4—Temozolomide—skin cancer	0.0299	0.233	CbGbCtD
Lomustine—CYP2D6—Vemurafenib—skin cancer	0.0258	0.201	CbGbCtD
Lomustine—CYP3A4—Vismodegib—skin cancer	0.0208	0.162	CbGbCtD
Lomustine—CYP3A4—Vemurafenib—skin cancer	0.0164	0.128	CbGbCtD
Lomustine—CYP3A4—Docetaxel—skin cancer	0.00563	0.0438	CbGbCtD
Lomustine—Azotaemia—Vismodegib—skin cancer	0.0027	0.0616	CcSEcCtD
Lomustine—Acute leukaemia—Temozolomide—skin cancer	0.00159	0.0363	CcSEcCtD
Lomustine—Fibrosis—Fluorouracil—skin cancer	0.00146	0.0334	CcSEcCtD
Lomustine—Pulmonary fibrosis—Bleomycin—skin cancer	0.00122	0.0279	CcSEcCtD
Lomustine—Hepatotoxicity—Vemurafenib—skin cancer	0.00115	0.0263	CcSEcCtD
Lomustine—Myelosuppression—Bleomycin—skin cancer	0.00115	0.0262	CcSEcCtD
Lomustine—Lung infiltration—Bleomycin—skin cancer	0.00115	0.0262	CcSEcCtD
Lomustine—Myelosuppression—Dactinomycin—skin cancer	0.00107	0.0244	CcSEcCtD
Lomustine—Acute leukaemia—Docetaxel—skin cancer	0.00106	0.0241	CcSEcCtD
Lomustine—Pulmonary fibrosis—Temozolomide—skin cancer	0.00103	0.0236	CcSEcCtD
Lomustine—Myelosuppression—Temozolomide—skin cancer	0.000967	0.0221	CcSEcCtD
Lomustine—Nephropathy toxic—Bleomycin—skin cancer	0.000936	0.0214	CcSEcCtD
Lomustine—Myelosuppression—Fluorouracil—skin cancer	0.000891	0.0204	CcSEcCtD
Lomustine—Neoplasm—Vemurafenib—skin cancer	0.000802	0.0183	CcSEcCtD
Lomustine—Pulmonary fibrosis—Docetaxel—skin cancer	0.000686	0.0157	CcSEcCtD
Lomustine—Hepatotoxicity—Dactinomycin—skin cancer	0.000649	0.0148	CcSEcCtD
Lomustine—Myelosuppression—Docetaxel—skin cancer	0.000643	0.0147	CcSEcCtD
Lomustine—Alopecia—Vismodegib—skin cancer	0.000637	0.0146	CcSEcCtD
Lomustine—Hepatotoxicity—Temozolomide—skin cancer	0.000587	0.0134	CcSEcCtD
Lomustine—Lethargy—Imiquimod—skin cancer	0.00056	0.0128	CcSEcCtD
Lomustine—Pancytopenia—Imiquimod—skin cancer	0.000451	0.0103	CcSEcCtD
Lomustine—Decreased appetite—Vismodegib—skin cancer	0.000445	0.0102	CcSEcCtD
Lomustine—Dysarthria—Fluorouracil—skin cancer	0.000442	0.0101	CcSEcCtD
Lomustine—Disorientation—Bleomycin—skin cancer	0.000436	0.00997	CcSEcCtD
Lomustine—Throat sore—Docetaxel—skin cancer	0.000418	0.00956	CcSEcCtD
Lomustine—Oropharyngeal discomfort—Docetaxel—skin cancer	0.000415	0.00948	CcSEcCtD
Lomustine—Neoplasm—Temozolomide—skin cancer	0.00041	0.00937	CcSEcCtD
Lomustine—Alopecia—Vemurafenib—skin cancer	0.000394	0.009	CcSEcCtD
Lomustine—Hepatotoxicity—Docetaxel—skin cancer	0.00039	0.00893	CcSEcCtD
Lomustine—Haemoglobin—Imiquimod—skin cancer	0.000382	0.00873	CcSEcCtD
Lomustine—Haemorrhage—Imiquimod—skin cancer	0.00038	0.00869	CcSEcCtD
Lomustine—Lethargy—Dactinomycin—skin cancer	0.000371	0.00849	CcSEcCtD
Lomustine—Visual impairment—Imiquimod—skin cancer	0.000366	0.00837	CcSEcCtD
Lomustine—Disorientation—Fluorouracil—skin cancer	0.000339	0.00775	CcSEcCtD
Lomustine—Alopecia—Imiquimod—skin cancer	0.000336	0.00768	CcSEcCtD
Lomustine—Oropharyngeal pain—Docetaxel—skin cancer	0.000332	0.00758	CcSEcCtD
Lomustine—Vomiting—Vismodegib—skin cancer	0.000326	0.00745	CcSEcCtD
Lomustine—Pancytopenia—Bleomycin—skin cancer	0.00032	0.00732	CcSEcCtD
Lomustine—Infection—Vemurafenib—skin cancer	0.000314	0.00719	CcSEcCtD
Lomustine—Ataxia—Temozolomide—skin cancer	0.000309	0.00708	CcSEcCtD
Lomustine—Lethargy—Fluorouracil—skin cancer	0.000309	0.00707	CcSEcCtD
Lomustine—Nausea—Vismodegib—skin cancer	0.000304	0.00696	CcSEcCtD
Lomustine—Osteoarthritis—Fluorouracil—skin cancer	0.000303	0.00693	CcSEcCtD
Lomustine—Pancytopenia—Dactinomycin—skin cancer	0.000299	0.00683	CcSEcCtD
Lomustine—Stomatitis—Bleomycin—skin cancer	0.000293	0.0067	CcSEcCtD
Lomustine—Ataxia—Fluorouracil—skin cancer	0.000285	0.00652	CcSEcCtD
Lomustine—Decreased appetite—Vemurafenib—skin cancer	0.000275	0.00629	CcSEcCtD
Lomustine—Stomatitis—Dactinomycin—skin cancer	0.000273	0.00625	CcSEcCtD
Lomustine—Neoplasm—Docetaxel—skin cancer	0.000273	0.00623	CcSEcCtD
Lomustine—Haemoglobin—Bleomycin—skin cancer	0.000271	0.0062	CcSEcCtD
Lomustine—Pancytopenia—Temozolomide—skin cancer	0.00027	0.00618	CcSEcCtD
Lomustine—Haemorrhage—Bleomycin—skin cancer	0.00027	0.00617	CcSEcCtD
Lomustine—Infection—Imiquimod—skin cancer	0.000268	0.00613	CcSEcCtD
Lomustine—Anorexia—Imiquimod—skin cancer	0.000257	0.00588	CcSEcCtD
Lomustine—Body temperature increased—Vemurafenib—skin cancer	0.00025	0.00572	CcSEcCtD
Lomustine—Pancytopenia—Fluorouracil—skin cancer	0.000249	0.00569	CcSEcCtD
Lomustine—Stomatitis—Temozolomide—skin cancer	0.000247	0.00565	CcSEcCtD
Lomustine—Alopecia—Bleomycin—skin cancer	0.000239	0.00545	CcSEcCtD
Lomustine—Decreased appetite—Imiquimod—skin cancer	0.000235	0.00536	CcSEcCtD
Lomustine—Visual disturbance—Docetaxel—skin cancer	0.000231	0.00528	CcSEcCtD
Lomustine—Haemoglobin—Temozolomide—skin cancer	0.000229	0.00523	CcSEcCtD
Lomustine—Stomatitis—Fluorouracil—skin cancer	0.000228	0.00521	CcSEcCtD
Lomustine—Haemorrhage—Temozolomide—skin cancer	0.000228	0.00521	CcSEcCtD
Lomustine—Lethargy—Docetaxel—skin cancer	0.000223	0.00511	CcSEcCtD
Lomustine—Alopecia—Dactinomycin—skin cancer	0.000222	0.00509	CcSEcCtD
Lomustine—Visual impairment—Temozolomide—skin cancer	0.000219	0.00502	CcSEcCtD
Lomustine—Body temperature increased—Imiquimod—skin cancer	0.000213	0.00488	CcSEcCtD
Lomustine—Haemoglobin—Fluorouracil—skin cancer	0.000211	0.00482	CcSEcCtD
Lomustine—Leukopenia—Bleomycin—skin cancer	0.00021	0.00481	CcSEcCtD
Lomustine—Haemorrhage—Fluorouracil—skin cancer	0.00021	0.0048	CcSEcCtD
Lomustine—Ataxia—Docetaxel—skin cancer	0.000206	0.00471	CcSEcCtD
Lomustine—Vomiting—Vemurafenib—skin cancer	0.000201	0.0046	CcSEcCtD
Lomustine—Alopecia—Temozolomide—skin cancer	0.000201	0.0046	CcSEcCtD
Lomustine—Leukopenia—Dactinomycin—skin cancer	0.000196	0.00448	CcSEcCtD
Lomustine—Infection—Bleomycin—skin cancer	0.000191	0.00436	CcSEcCtD
Lomustine—Nausea—Vemurafenib—skin cancer	0.000188	0.0043	CcSEcCtD
Lomustine—Thrombocytopenia—Bleomycin—skin cancer	0.000188	0.00429	CcSEcCtD
Lomustine—Alopecia—Fluorouracil—skin cancer	0.000185	0.00424	CcSEcCtD
Lomustine—Anorexia—Bleomycin—skin cancer	0.000183	0.00418	CcSEcCtD
Lomustine—Pancytopenia—Docetaxel—skin cancer	0.00018	0.00411	CcSEcCtD
Lomustine—Infection—Dactinomycin—skin cancer	0.000178	0.00406	CcSEcCtD
Lomustine—Leukopenia—Temozolomide—skin cancer	0.000177	0.00406	CcSEcCtD
Lomustine—Thrombocytopenia—Dactinomycin—skin cancer	0.000175	0.004	CcSEcCtD
Lomustine—Vomiting—Imiquimod—skin cancer	0.000172	0.00392	CcSEcCtD
Lomustine—Anorexia—Dactinomycin—skin cancer	0.00017	0.0039	CcSEcCtD
Lomustine—Decreased appetite—Bleomycin—skin cancer	0.000167	0.00381	CcSEcCtD
Lomustine—Renal failure—Docetaxel—skin cancer	0.000166	0.00379	CcSEcCtD
Lomustine—Stomatitis—Docetaxel—skin cancer	0.000164	0.00376	CcSEcCtD
Lomustine—Leukopenia—Fluorouracil—skin cancer	0.000163	0.00374	CcSEcCtD
Lomustine—Infection—Temozolomide—skin cancer	0.000161	0.00367	CcSEcCtD
Lomustine—Nausea—Imiquimod—skin cancer	0.00016	0.00367	CcSEcCtD
Lomustine—Thrombocytopenia—Temozolomide—skin cancer	0.000158	0.00362	CcSEcCtD
Lomustine—Decreased appetite—Dactinomycin—skin cancer	0.000155	0.00355	CcSEcCtD
Lomustine—Anorexia—Temozolomide—skin cancer	0.000154	0.00353	CcSEcCtD
Lomustine—Haemoglobin—Docetaxel—skin cancer	0.000152	0.00348	CcSEcCtD
Lomustine—Body temperature increased—Bleomycin—skin cancer	0.000152	0.00347	CcSEcCtD
Lomustine—Haemorrhage—Docetaxel—skin cancer	0.000151	0.00346	CcSEcCtD
Lomustine—Infection—Fluorouracil—skin cancer	0.000148	0.00339	CcSEcCtD
Lomustine—Thrombocytopenia—Fluorouracil—skin cancer	0.000146	0.00334	CcSEcCtD
Lomustine—Visual impairment—Docetaxel—skin cancer	0.000146	0.00334	CcSEcCtD
Lomustine—Anorexia—Fluorouracil—skin cancer	0.000142	0.00325	CcSEcCtD
Lomustine—Body temperature increased—Dactinomycin—skin cancer	0.000141	0.00323	CcSEcCtD
Lomustine—Decreased appetite—Temozolomide—skin cancer	0.000141	0.00321	CcSEcCtD
Lomustine—Alopecia—Docetaxel—skin cancer	0.000134	0.00306	CcSEcCtD
Lomustine—Decreased appetite—Fluorouracil—skin cancer	0.00013	0.00296	CcSEcCtD
Lomustine—Body temperature increased—Temozolomide—skin cancer	0.000128	0.00292	CcSEcCtD
Lomustine—Vomiting—Bleomycin—skin cancer	0.000122	0.00279	CcSEcCtD
Lomustine—Leukopenia—Docetaxel—skin cancer	0.000118	0.0027	CcSEcCtD
Lomustine—Body temperature increased—Fluorouracil—skin cancer	0.000118	0.00269	CcSEcCtD
Lomustine—Nausea—Bleomycin—skin cancer	0.000114	0.0026	CcSEcCtD
Lomustine—Vomiting—Dactinomycin—skin cancer	0.000114	0.0026	CcSEcCtD
Lomustine—Infection—Docetaxel—skin cancer	0.000107	0.00244	CcSEcCtD
Lomustine—Nausea—Dactinomycin—skin cancer	0.000106	0.00243	CcSEcCtD
Lomustine—Thrombocytopenia—Docetaxel—skin cancer	0.000105	0.00241	CcSEcCtD
Lomustine—Vomiting—Temozolomide—skin cancer	0.000103	0.00235	CcSEcCtD
Lomustine—Anorexia—Docetaxel—skin cancer	0.000103	0.00234	CcSEcCtD
Lomustine—Nausea—Temozolomide—skin cancer	9.61e-05	0.0022	CcSEcCtD
Lomustine—Vomiting—Fluorouracil—skin cancer	9.48e-05	0.00217	CcSEcCtD
Lomustine—Decreased appetite—Docetaxel—skin cancer	9.35e-05	0.00214	CcSEcCtD
Lomustine—Nausea—Fluorouracil—skin cancer	8.85e-05	0.00202	CcSEcCtD
Lomustine—Body temperature increased—Docetaxel—skin cancer	8.5e-05	0.00194	CcSEcCtD
Lomustine—Vomiting—Docetaxel—skin cancer	6.84e-05	0.00156	CcSEcCtD
Lomustine—Nausea—Docetaxel—skin cancer	6.39e-05	0.00146	CcSEcCtD
